Literature DB >> 3721435

First do no harm: short-term inpatient psychotherapy of the borderline patient.

L I Sederer, J Thorbeck.   

Abstract

Patients with borderline personality disorder typically are hospitalized in the midst of a crisis and in a state of acute regression. After a few days in which the patient is provided with containment and support, the therapist can assess whether the patient has the capacity for exploratory psychotherapy that may help in ego development or whether such psychotherapy may prompt further regression and dangerous acting out. For exploratory therapy certain conditions, such as an observing ego, a therapeutic alliance, and the therapist's ability to contain countertransference feelings and deal with the patient's projections, are essential. The therapist must be alert to common treatment errors that can undermine the patient's capacity to recompensate; they are likely to occur in the areas of empathy, confrontation, transference, interpretation and management, and the patient's attachment to pain.

Entities:  

Mesh:

Year:  1986        PMID: 3721435     DOI: 10.1176/ps.37.7.692

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  4 in total

1.  Living and learning with managed care.

Authors:  J M Lewis; M J Blotcky
Journal:  Acad Psychiatry       Date:  1993-12

Review 2.  Developing a systems approach to caring for persons with borderline personality disorder.

Authors:  N Nehls; R J Diamond
Journal:  Community Ment Health J       Date:  1993-04

Review 3.  The application of dialectical behavior therapy for patients with borderline personality disorder on inpatient units.

Authors:  C R Swenson; C Sanderson; R A Dulit; M M Linehan
Journal:  Psychiatr Q       Date:  2001

4.  An updated model for the first-time hospitalization of patients with borderline personality disorder: two illustrative case reports.

Authors:  Jonathan Avery; Dimitry Francois; Olga Martins; Steve Park; Steven Roth
Journal:  Psychiatr Q       Date:  2012-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.